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Escherichia coli O157:H7 variants were examined for 
trait mutations and by molecular subtyping to better deﬁ  ne 
clonal complexes postulated on the O157:H7 evolution 
model. Strains of β-glucuronidase–positive, sorbitol-nega-
tive O157:H7 isolated in United States and Japan were 
identical to A5 clonal strain and shared sequence type 
(ST)–65 by multilocus sequence typing (MLST); thus, they 
belong in A5. However, these strains exhibited pulsed-ﬁ  eld 
gel electrophoresis (PFGE) proﬁ   le differences that sug-
gested genomic divergence between populations. Sorbitol-
fermenting O157 (SFO157) strains from Finland, Scotland, 
and Germany were identical to A4 clonal strain and belong 
in A4. Some SFO157 strains, isolated years apart and from 
different countries, had identical PFGE proﬁ  les, suggesting 
a common origin. Despite similarities, some Finnish and 
Scottish and all of the German strains have ST-75 (“German 
clone”), whereas others have ST-76, a new variant (“Scot-
tish clone”). MLST of strains in other clonal complexes also 
discriminated strains thought to be identical and showed 
that genetic differences will further distinguish clonal popu-
lations into subclones.
A
n evolutionary model postulates that Escherichia coli 
O157:H7 evolved from ancestral E. coli by stepwise 
acquisition or loss of virulence and phenotypic traits (1). 
At the center of the model is a hypothetical “intermediate” 
strain (ancestor A3), which evolved from the A2 clonal com-
plex of O55:H7 strains that are closely related but ancestral 
to O157:H7 (2). It is hypothesized that the A3 intermediate 
strain is a missing link, a primitive O157:H7 that ferments 
sorbitol (SOR), is β-glucuronidase positive (GUD+), and 
has the Shiga toxin 2 gene (stx2), and from which evolved 2 
distinct pathways. The loss of SOR phenotype and the ac-
quisition of stx1 gene led to the emergence of the A5 clonal 
complex of SOR–, GUD+ O157:H7 strains, which then 
lost GUD expression, resulting in the prototypic O157:H7 
clonal complex (A6). Also from A3 emerged a divergent 
lineage caused in part by the loss of motility giving rise to 
the A4 clonal complex of SOR+, GUD+, nonmotile strains 
that are designated as SFO157. These clonal complexes on 
the model were predicted on the basis of phenotypes, mul-
tilocus enzyme electrophoresis (MLEE), and the presence 
of the +93 single nucleotide polymorphisms (SNP) in the 
uidA gene that encode for GUD (1). However, except for 
the A6 clonal complex (O157:H7), from which strains were 
readily available, only a few strains existed for the other 
clonal complexes. As a result, these clonal complexes were 
not well deﬁ  ned because of the limited characterization cri-
teria used and the lack of strains.
Molecular typing methods have improved the ability 
to characterize and discriminate closely related strains. Ge-
netic studies have also elucidated some of the mutations 
that occurred in the stepwise emergence of clonal complex-
es. For example, in the transition from A5 to A6, the loss 
of GUD expression was found to be due to a frame-shift 
mutation caused by G-G insertion at +686 in the uidA gene 
(3). Similarly, in the divergence of A4 from A3, the loss of 
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motility was caused by a 12-bp deletion in the ﬂ  hC ﬂ  agella 
master regulon gene (4). These mutations provide unique 
markers for tracing the model’s evolutionary events and, 
coupled with better typing methods, have provided more 
discriminatory means to reexamine genetic relatedness 
among O157:H7 clonal complexes.
In addition, new or previously rare strains have been 
isolated more frequently. The A5 clonal complex of GUD+ 
O157:H7 was represented solely by strain G5101, isolated 
from a hemorrhagic colitis patient in the United States in 
1994 (5). Similarly, the A4 clone complex of SFO157 was 
represented by 493–89 and a few other German strains iso-
lated from hemolytic uremic syndrome (HUS) patients in 
Bavaria in 1988 (6). Recently, however, GUD+ O157:H7 
strains have been isolated in the United States and from 
outbreaks and sporadic infections in Hokkaido, Japan (7). 
Likewise, SFO157 strains, which have also been isolated 
from cattle (8), are increasingly causing sporadic infections 
and outbreaks of HUS (9,10) and have been isolated in the 
Czech Republic (11), Finland (12,13), Scotland (14), and 
other countries (6). 
In this study, we examined strains from various clonal 
complexes, including GUD+ O157:H7 strains from the 
United States and Japan and SFO157 strains from Finland, 
Scotland, and Germany, for unique mutational markers. 
We also used molecular typing to better deﬁ  ne the various 
clonal complexes in the O157:H7 evolution model.
Materials and Methods
Bacterial Strains
The 3 GUD+ O157:H7 strains from the United States 
were originally isolated from clinical samples, and the 22 
strains from Japan were isolated from outbreak patients 
with diarrhea or no symptoms and sporadic cases in Hok-
kaido (7). The SFO157 strains included 8 from Germany 
(15), 8 from Finland (13), and 5 from Scotland (14). Most 
of these were isolated from patients with symptoms of 
hemorrhagic colitis or HUS. However, 3 Scottish strains 
(designated H1085 and variations thereof) were isolated 
from cat feces at a farm where a hemorrhagic colitis in-
fection had occurred. The other strains examined are from 
the Food and Drug Administration (FDA) and the Shiga 
Toxin-Producing Escherichia coli Center (Michigan State 
University, East Lansing, MI, USA), except for LSU-61, an 
O157:H7 strain isolated from deer (16).
Characterization
To reconﬁ  rm their phenotypic traits, strains were plat-
ed on ceﬁ  xime-tellurite sorbitol MacConkey agar (Bacte-
riological Analytical Manual, www.cfsan.fda.gov/~ebam/
bam-4a.html) to test for SOR fermentation and resistance 
to 2.5 μg/mL potassium tellurite. The plates also had a Col-
iComplete disc (BioControl, Bellevue, WA, USA) to test 
for GUD activity. All isolates were serotyped for O157 and 
H7 antigens (RIM O157:H7, Remel, Lenexa, KS, USA) 
and tested by several PCR assays for trait virulence genes, 
mutational markers, and SNPs. A multiplex PCR (17) was 
used to test for stx1, stx2, γ-eae for intimin, ehxA for entero-
hemolysin, and the +93 SNP in the uidA. The GUD+ O157:
H7 strains were tested for the +776 SNP and for the +686 
G-G insertion in uidA (3); the SFO157 strains were tested 
for the presence of the H7 ﬂ  iC gene and for the 12-bp ﬂ  hC 
deletion (4). Shiga toxin (Stx) production was veriﬁ  ed se-
rologically with the Verotoxin-producing E. coli–Reversed 
Passive Latex Agglutination Test (Denka Seiken, Japan), 
and enterohemolysin activity was tested on Ca++ blood agar 
plates (18).
Pulsed-Field Gel Electrophoresis (PFGE)
XbaI-digested genomic DNA was analyzed in 1% aga-
rose gel in 0.5× Tris-boric acid-EDTA TBE buffer at 14°C 
by using CHEF MAPPER (BioRad, Hercules, CA, USA) 
(19). The runtime was 18 h at 6V/cm, with initial and ﬁ  -
nal switch times of 2.16 and 54.17 s, respectively. The gel 
was stained with ethidium bromide (1 μg/mL), observed 
on the Gel Doc 2000 system (BioRad), and analyzed with 
the BioNumerics ﬁ  ngerprinting software (Applied Maths, 
St-Martens-Latem, Belgium).
Multilocus Sequence Typing (MLST)
The MLST protocol (www.shigatox.net/cgi-bin/mlst7/
index) uses PCR primers to amplify internal segments of 
7 speciﬁ  c housekeeping genes (aspartate aminotransferase 
[aspC], caseinolytic protease [clpX], acyl-CoA synthetase 
[fadD], isocitrate dehydrogenase [icdA], lysine permease 
[lysP], malate dehydrogenase [mdh] and uidA), which are 
puriﬁ  ed and sequenced. Each unique sequence is given an 
allele number, and the combinations of alleles from the 7 
genes are used to compile the organism’s allelic proﬁ  le. 
Each unique proﬁ  le is designated as a sequence type (ST), 
which is then compared with those of other pathogenic E. 
coli strains in the EcMLST database (20).
Results
Strain Characterizations
All the GUD+ O157:H7 strains examined had traits 
identical to the A5 type strain (G5101); were SOR–, GUD+, 
and  tellurite resistant; and produced both O157 and H7 an-
tigens (Table 1). Except for 2 US strains (TW06289 and 
TW06290) that did not have stx1, all carried stx1, stx2, γ-
eae, ehxA, and the +93 uidA SNP. Serologic analysis con-
ﬁ  rmed the production of both Stx, and all strains also had 
enterohemolysin activity. All GUD+ O157:H7 strains had 
the +776 SNP and, consistent with their GUD+ phenotype, 
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did not have the +686 uidA G-G insertion. Because these 
strains expressed H7, they were not tested for the H7 ﬂ  iC 
gene or for the ﬂ  hC deletion.
All SFO157 strains examined were SOR+, GUD+, and 
tellurite sensitive, and expressed the O157 but not the H7 
antigen (Table 1). Despite the absence of H7, all strains 
carried the H7 ﬂ  iC gene. Except for 2 German (210–89, 
CB1009) and 2 Finnish (IH56929, IH56776) strains that 
did not have stx, all SFO157 carried only stx2, γ-eae, +93 
uidA SNP, and the 12-bp ﬂ  hC deletion, but not the +776 
uidA SNP. Since SFO157 strains are GUD+, they were not 
tested for the +686 insertion in uidA. Also, except for strain 
H1085 1a/1, all SFO157 strains carried ehxA, but none had 
enterohemolysin activity. All these traits are consistent 
with those of the A4 type strain (493–89).
Analysis of LSU-61 showed that it had a mix of traits 
from various clonal complexes. It is SOR+, GUD+, tellu-
rite resistant, and had both O157 and H7 antigens. It had 
the +93 SNP but not the +776 SNP in uidA; had no stx; had 
γ-eae and ehxA; and showed enterohemolytic activity on 
blood agar plates (Table 1).
Molecular Subtyping
PFGE proﬁ  les of the US and 11/22 Japanese GUD+ 
O157:H7 strains are shown in Figure 1. The Japanese 
strains had nearly identical proﬁ  les, showing >95% simi-
larity. Among the US strains, TW09099 and G5101 shared 
≈90% similarity, but the other 2 strains were only 75% sim-
ilar to G5101. The proﬁ  les of the US and Japanese strains 
shared only ≈70% similarity overall. MLST showed that all 
GUD+ O157:H7, including G5101, had ST-65 (Table 2).
The PFGE proﬁ   les of some SFO157 strains isolat-
ed within Germany (1782/88 and 4326/93) and Finland 
(IH57086 and IH57225) were identical (Figure 2). But pro-
ﬁ  le identity was also observed among strains from Finland 
(IH56906) and Scotland (H1085c and H2687) and strains 
from Finland (IH56929) and Germany (5412/89) (Figure 2). 
MLST analysis showed that all the German, 4 Finnish, and 
1 Scottish strain had ST-75 but that the other 4 Scottish 
strains and the rest of the Finnish strains had a distinct mdh 
allele and were genotyped as ST-76 (Table 2).
Discussion
The stepwise evolutionary model postulates that an-
cestral O157 clonal group (A3) split into 1 lineage, leading 
to the common GUD–, SOR– O157:H7 (NSF O157) clonal 
complex (A6) and a second branch of SFO157 that retained 
many primitive traits (A4) (Figure 3). The A4 and A5 clon-
al complexes on the evolution model are closely related to 
O157:H7 (A6 clonal complex) (Figure 3) and share many 
traits, including the +93 uidA SNP, which is found only in 
O157:H7 and its nonmotile variants (1). Another common 
trait is the γ-eae allele, which is also found in few other se-
rotypes (21), including the O55:H7 strains in the A2 clonal 
complex that is ancestral to O157:H7 (2) (Figure 3). The 
A5 clonal complex of GUD+ O157:H7 strains is postulated 
to have emerged from the A3 intermediate strain. Analysis 
of A5 type strain (G5101) showed that it carried a +776 
uidA SNP, which appears to have been acquired before the 
emergence of A5, because it is found only in A5 strains and 
A6 clonal complex of O157:H7 strains (3). All the GUD+ 
O157:H7 strains tested had identical traits as G5101, in-
cluding the unique uidA markers (+93 and +776 SNP and 
absence of +686 G-G insertion) that are consistent with the 
mutational events postulated for the emergence of A5 and 
conﬁ  rm that these strains also belong in A5. The fact that 
all these GUD+ O157:H7 strains have ST-65 supports that 
conclusion (Table 2). Despite similarities, however, there 
were differences in PFGE proﬁ  les. The Japanese strains 
had nearly identical PFGE proﬁ  les, which is consistent 
with the results by Nagano et al. (7), who also observed 
proﬁ  le identity among clinical and environmental GUD+ 
O157:H7 isolates in Japan (22). In contrast, the US strains 
showed more diversity and shared only 70% similarity with 
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Table 1. Characteristics of Escherichia coli O157 strains* 
Source No. SOR GUD ΤeO 1 5 7H 7 fliC stx1 stx2 γeae ehxA +93 +776 +686 BAP ΔflhC
G5101 – + R + + + + + + + + + – + –
USA 1 – + R + + ND + + + + + + – + NA
2 – +R++ N D –+++++–+ N A
J a p a n 2 2– +R++ N D ++++++–+ N A
498/89 + + S + – + – + + + + – NA – +
G e r m a n y  5 + +S+–+–++++– N A –+
2 + +S+–+––+++– N A –+
Scotland 4 + + S + – + – + + + + – NA – +
1 + +S+–+–++–+– N A –+
Finland 6 + + S + – + – + + + + – NA – +
2 + +S+–+––+++– N A –+
LSU-61 + + R + + + – – + + + – NA + –
*SOR, sorbitol fermentation; GUD, β-glucuronidase activity; Te, tellurite resistant (R) or sensitive (S); O157, antigen; H7, antigen; fliC, H7 flagella gene; 
stx1, shiga toxin 1 gene; stx2, shiga toxin 2 gene; γeae, γ-intimin; ehxA, enterohemolysin gene; +93, uidA single nucleotide polymorphisms (SNP); +776, 
uidA SNP; +686, uidA G-G insertion; BAP, enterohemolysin activity on blood agar plates; ΔflhC, 12-bp deletion; ND, not done; NA, not applicable. RESEARCH
the Japanese strains, which suggests the occurrence of re-
cent genomic divergences among the US populations of 
GUD+ O157:H7 strains.
The SFO157 strains of A4 clonal complex were also 
postulated to have evolved from the A3 intermediate strain 
(Figure 3). Analysis of the A4 type strain 493–89 showed 
that a key mutation that led to the emergence of A4 was the 
loss of motility caused by the 12-bp ﬂ  hC deletion (4). Oth-
er A4 traits included tellurite sensitivity and the carriage of 
both ehxA and the H7 ﬂ  iC, neither of which is expressed. 
All the SFO157 strains tested had these markers, which 
were postulated to have been acquired in the emergence of 
A4, which conﬁ  rmed that these SFO157 strains also belong 
in the A4 clonal complex. The genomic similarities of the 
SFO157 strains are also reﬂ  ected in their PFGE proﬁ  les, as 
2 German strains (1782/88 and 4326/93) isolated 5 years 
apart had identical proﬁ  les; a Finnish strain (IH56909) iso-
lated in 1999 was identical to 2 Scottish strains (H1085c, 
H2687) that were isolated in 2003; and a Finnish strain 
(IH56929) was identical to a German strain (5412/89) that 
was isolated 10 years earlier. These results are consistent 
with similarities observed among SFO157 strains from 
Germany (15), Finland (12,13), and the Czech Republic 
(11). The fact that there are proﬁ  le identities among strains 
isolated years apart and from different geographic areas 
suggests that these SFO157 strains isolated from various 
European countries may have a common origin. Despite 
PFGE proﬁ  le similarities, MLST showed genetic differ-
ences within the SFO157 populations (Table 2). The Ger-
man, 4 Finnish, and 1 Scottish strain (H1410) had ST-75, 
which we designated as the “German clone,” while the re-
maining Scottish and Finnish strains had ST-76 (“Scottish 
clone”) (Figure 3). This genetic difference existed among 
strains with identical PFGE proﬁ   les, as German strain 
5412/89 and Finnish strain IH56929 had ST-75 and ST-
76, respectively.
Preliminary studies show that MLST (Table 2) may 
also better deﬁ  ne other clonal complexes. In the A6 com-
plex of O157:H7 strains, the Sakai strain that caused out-
breaks in Japan and 2 US strains had identical lysP alleles 
(ST-66) but were distinct from the commonly used EDL933 
reference strain (ST-69), a ﬁ  nding that suggests that genetic 
differences may also further distinguish the A6 clonal com-
plex into subclones (Figure 3).
The A1 clonal complex, which consists of O55:H7 
strains that are SOR+, GUD+, and carry γ-eae, was postu-
lated to have given rise to A2 by the acquisition of the stx2 
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Table 2. Sequence type, serotype, and isolation information of 
strains of Escherichia coli
Sequence
type  Strain Source Year Serotype 
65* G5101 USA 1995 O157:H7 
EC96038 Japan 1996 O157:H7 
EC96024 Japan 1996 O157:H7 
EC97144 Japan 1997 O157:H7 
TW09099 USA 2003 O157:H7 
TW06290 USA 1997 O157:H7 
TW06289 USA 1997 O157:H7 
66 86–24 USA 1986 O157:H7 
93–111 USA 1993 O157:H7 
Sakai Japan 1996 O157:H7 
69 EDL-933 USA 1982 O157:H7 
73 C586–65 Sri Lanka 1965 O55:H7
TB182A USA 1991 O55:H7
5905 USA 1994 O55:H7
3256–97 USA 1997 O55:H7
75 493/89 Germany 1989 O157:H– 
1782/88 Germany 1988 O157:H– 
5412/89 Germany 1989 O157:H– 
CB569 Germany 1987 O157:H– 
210/89 Germany 1989 O157:H– 
CB1009 Germany 1990 O157:H– 
514/91 Germany 1991 O157:H– 
4326/93 Germany 1993 O157:H– 
IH 53440 Finland 1997 O157:H– 
IH 56776 Finland 1998 O157:H– 
IH 57086 Finland 1999 O157:H– 
H1410 Scotland 2002 O157:H– 
IH 57225 Finland 1990s O157:H– 
76 IH 57201 Finland 1999 O157:H– 
IH 56909 Finland 1999 O157:H– 
IH 56969 Finland 1999 O157:H– 
IH 56929 Finland 1999 O157:H– 
H2687 Scotland 2003 O157:H– 
H1085C Scotland 2003 O157:H– 
H1085 3a Scotland 2003 O157:H– 
H1085 1a/1 Scotland 2003 O157:H– 
77 ECOR-37† USA 1970s Ont:Hnt
237 LSU-61 USA 2001 O157:H7 
*Only selected β-glucuronidase positive O157:H7 strains from Japan are 
shown. 
†Not typeable.
Figure 1. Pulsed-ﬁ   eld gel electrophoresis of XbaI-digested DNA 
from GUD+ O157:H7 strains. Strain designation, source and year 
of isolation are shown at right. This unweighted pair-group method 
with arithmetic mean dendrogram was generated in BioNumerics 
software (Applied Maths, St-Martens-Latem, Belgium) by using Die 
coefﬁ  cient with a 1.0% lane optimization and 1.0% band position 
tolerance. The scale above the dendrogram indicates percent 
similarity.Genetic Diversity and O157:H7 Clonal Complex Populations
phage (1). Based on phenotypes, 2 O55:H7 strains (C586–
65 and TB182A) that did not have stx were previously 
thought to be A1 strains, but MLST showed both strains to 
have ST-73, identical to the Stx2-producing O55:H7 strains 
(5905 and 3256–97) in the A2 clonal complex (Table 2). 
Analogous to the data obtained with the GUD+ O157:
H7 strains, these O55:H7 strains had the same ST, but the 
PFGE proﬁ  les of C586–65 and TB182A shared only 60% 
similarity to 5905 and 3256–97 (data not shown). The ge-
netic data on the transition from A1 to A2 is limited, so it is 
uncertain whether C586–65 and TB182A are derivatives of 
A1 or, perhaps, are A2 strains that have lost the stx2  phage 
(see below).
Similarly, a marmoset isolate of E. coli (ECOR37) was 
previously shown to be closely related to A2 by MLEE. 
This strain had A2-like traits, including γ-eae (23), but its O 
and H antigens were serologically untypeable. PCR testing 
showed that ECOR37 had both the O55 wzx gene, required 
for export of O lipopolysaccharide, and the H7 ﬂ  iC gene 
(data not shown) and, therefore, is an O55:H7 strain. How-
ever, ECOR37 shared only 60% similarity in PFGE pro-
ﬁ  les with A2 strains (data not shown). MLST also showed 
ECOR37 to have distinct mdh and clpX alleles (ST-77) 
(Table 2) and so this strain does not appear to belong in 
the A2 clonal complex (ST-73). We can only speculate that 
ECOR37 is an ancestral strain of A1 and A2, but its posi-
tion in the model is uncertain (Figure 3).
LSU-61 is an O157:H7 that is SOR+; GUD+; tellurite 
resistant; carried γ-eae, ehxA, the +93, but not the +776 
uidA SNP; and had no stx. Except for the absence of stx2, 
LSU-61 had many of the traits proposed for the A3 inter-
mediate, which has not yet been isolated. If LSU-61 is 
the A3 intermediate strain, we would expect it to be ge-
netically related to the other clones because A3 is thought 
to have evolved from A2 and to be the intermediate for 
both A4 and A5 (Figure 3). However, the PFGE proﬁ  le of 
LSU-61 showed only 60% similarity to stains in the A2, 
A4, A5, and A6 clonal complexes (data not shown), and 
it had a distinct fadD allele (ST-237) (Table 2). Despite 
these dissimilarities, the fact that LSU-61 has both O157 
and H7 antigens and carries traits of neighboring clonal 
complexes (especially +93 uidA SNP and γ-eae) is com-
pelling evidence that it belongs in the O157:H7 complex. 
The absence of the +776 uidA SNP in LSU-61 indicates 
that it is ancestral to A5; however, the exact position of 
LSU-61 on the evolutionary model remains to be deter-
mined (Figure 3).
In our study, we encountered various strains that had 
identical STs and traits as the clonal type strains, except 
for stx. Both stx1 and stx2 are phage encoded, and there is 
great diversity in stx-phage insertion sites among strains 
(24). Sometimes, these phages may be induced, resulting 
in strains that have lost the ability to produce Stx (25) or 
conversely, strains may acquire the ability to produce Stx 
by phage infection. This acquisition or loss of stx phages 
shows that this trait may not be a stable marker. Thus, the 
association of stx genotypes with clonal complexes should 
be interpreted with caution.
In summary, the use of unique trait markers and mo-
lecular typing methods better deﬁ  ned some of the clonal 
complexes postulated on the O157:H7 evolution model. 
The GUD+ O157:H7 and the SFO157 strains obtained 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 11, November 2007  1705 
Figure 2. Pulsed-ﬁ   eld gel electrophoresis of XbaI-digested DNA 
from SFO157 strains. Strain designation, source, and year of 
isolation are shown at right. This unweighted pair-group method 
with arithmetic mean dendrogram was generated in BioNumerics 
software (Applied Maths, St-Martens-Latem, Belgium) by using Die 
coefﬁ  cient with a 1.0% lane optimization and 1.0% band position 
tolerance. The scale above the dendrogram indicates percent 
similarity.
Figure 3. Evolution model for Escherichia coli O157:H7. Figure 
modiﬁ  ed and updated from (1) to include the sequence type (ST) 
data showing subclones within clonal complexes. Some strains, 
whose position on the model remains to be determined, are shown 
with dashed lines.RESEARCH
worldwide had the unique mutation markers postulated for 
the emergence of the A5 and A4 clonal types and, there-
fore, belonged in these respective clonal complexes. Mo-
lecular subtyping showed genetic similarities and identities 
among strains within clonal complexes, but MLST identi-
ﬁ  ed genetic differences that further segregated these strains 
into subclones within a clonal complex.
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